---
DrugClass: "[[Antiparkinson]]"
SubClass: "[[Dopaminergic Drugs]]"
DrugClassContra: "[[Dopaminergic Drugs#Contraindications]]"
DrugClassAdverse: "[[Dopaminergic Drugs#Adverse Reactions]]"
SecondaryDrugClass: 
SecondarySubClass: 
BrandName: 
Chapter: "27"
KindleLinkChap: "[Chapter 27](kindle://book?action=open&asin=B09FRF11YJ&location=14154)"
KindleLink: 
tags:
  - Drug
  - Pharmacology
Course: Pharmacology
ChemLink: https://pubchem.ncbi.nlm.nih.gov/#query=
---
```smiles
C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)O
```

### Brand name
`=this.BrandName`

### Generic name
`= this.file.name`

### Drug class 
`= this.DrugClass`
	`= this.DrugClass.KindleLinkChap`

### Dosage & Usage
Parkinson disease 
0.5â€“ 1 g/ day orally initially, not to exceed 8 g/ day 

### Contraindications
See `= this.DrugClassContra`

### Mechanisms of Action
Levodopa by various routes crosses the blood brain barrier, is decarboxylated to form dopamine. This supplemental dopamine performs the role that endogenous dopamine cannot due to a decrease of natural concentrations and stimulates dopaminergic receptors.

### Side/Adverse Effects
See `= this.DrugClassAdverse`
Same as [[carbidopa-levodopa#Side/Adverse Effects]]

### Interactions

`= this.ChemLink+this.file.name`

